Method of activating T cells with lymphokine SAF

Details Method of activating T cells with lymphokine SAF Method of activating T cells with lymphokine SAF

1993-07-02

1995-06-27

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Involving sex selection or contraception

530350, 530351, 514 2, 514 8, 514 12, 424545, 4241981, 4352402, A61K 3819, C07K 1452

Patent

active

054277817

ABSTRACT:
A lymphokine is taught which can be used to activate and stimulate CD3.sup.+, CD4.sup.+ T cells, as well as Sezary leukemic T cells. The lymphokine can be obtained from mitogen-stimulated peripheral blood mononuclear cells or urine of Sezary Syndrome patients. The lymphokine upregulates interleukin-2 receptors.

REFERENCES:
patent: 5225535 (1993-07-01), DeFrietas et al.
Balkwill and Burke Immunol Today 10(9):299-303 (1989).
Solbach et al., 1984, "Growth, Interleukin-2 Production, and Responsiveness to IL-2 in T4-Positive T Lymphocyte Population From Malignant Cutaneous T Cell Lymphoma (Sezary's Syndrome): The Effect of Cyclosporine A," Blood, 64(5):1022-1027.
Maeda et al., 1985, "Origin of Human T-Lymphotrophic Virus I-Positive T Cell Lines in Adult T Cell Leukemia," J. Exp. Med., 162:2169-2174.
Okada et al., 1985, "TCGF (IL 2)-Receptor Inducing Factor(s), II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines," J. Immunol. 135:3995-4003.
Yodoi et al., 1985, "TCGF (IL 2)-Receptor Inducing Factor(s), I. Regulation of II 2 Receptor on a Natural Killer-like Cell Line (YT Cells)," J. Immunol., 134(3):1623-1630.
Rimsky et al., 1986, "Purification to Homogeneity and NH.sub.2 -terminal Amino Acid Sequence of a Novel Interleukin 1 Species Derived from a Human B Cell Line," J. Immunol., 136:3304-3310.
Wakasurgi et al., 1987, "Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it used as a growth factor," Proc. Natl. Acad. Sci. USA, 84:804-808.
Tagaya et al., 1988, "IL-2 Receptor(P55)/TAC-Inducing Factor, Purification and Characterization of Adult T Cell Leukemia-Derived Factor," J. Immunol., 140:2614-2620.
Namen et al., 1988, "B Cell Precursor Growth-Promoting Activity, Purification and Characterization of a Growth Factor Active on Lymphocyte Precursors," J. Exp. Med., 167:988-1002.
Maeda et al., 1988, "Application of a human T cell line derived from a Sezary syndrome patient for human interleukin 4 assay," Immunol. Lett., 18(4):247-254.
Armitage et al., 1990, "Regulation of Human T Cell Proliferation by IL-7," J. Immunol., 144:938-941.
Henney, 1989, "Interleukin 7: effects on early events in lymphopoiesis," Immunol. Today, 10:170-173.

Affiliated with

Also associated with

Rating

Method of activating T cells with lymphokine SAF does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of activating T cells with lymphokine SAF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of activating T cells with lymphokine SAF will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-285539